Showing results (1-10 of 227) with videos related to
Sort By:
Pageof 23
Current Atherosclerosis Reports|January 3, 2025
Homozygous Familial Hypercholesterolemia Treatment: New DevelopmentsDirk J Blom, A David Marais, Frederick J RaalCurrent Atherosclerosis Reports|November 20, 2019
Lomitapide and Mipomersen-Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 SynthesisDirk J Blom, Frederick J Raal, Raul D Santos, et al.European Heart Journal|November 7, 2017
Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterolGilbert R Thompson, Dirk J Blom, A David Marais, et al.Circulation|October 12, 2011
Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapyFrederick J Raal, Gillian J Pilcher, Vanessa R Panz, et al.Circulation. Genomic and Precision Medicine|September 26, 2022
Familial Hypercholesterolemia Identification by Machine Learning Using Lipid Profile Data Performs as Well as Clinical Diagnostic CriteriaReinhardt Hesse, Frederick J Raal, Dirk J Blom, et al.Cardiovascular Journal of Africa|November 19, 2013
Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)Frederick J Raal, Dirk J Blom, Shanil Naidoo, et al.Atherosclerosis|October 2, 2018
Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnanciesTheunis C Botha, Gillian J Pilcher, Karen Wolmarans, et al.Journal of Lipid Research|January 9, 2003
Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemiaDirk J Blom, Pamela Byrnes, Sheena Jones, et al.Atherosclerosis|December 4, 2003
Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemiaFrederick J Raal, A David Marais, Ellen Klepack, et al.Current Atherosclerosis Reports|March 31, 2022
Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E IsoformsKévin Chemello, Dirk J Blom, A David Marais, et al.Pageof 23